Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000659837 | SCV000781703 | likely benign | Noonan syndrome 3 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091902 | SCV005758664 | uncertain significance | RASopathy | 2024-07-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg164*) in the KRAS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 25 amino acid(s) of the KRAS protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KRAS-related conditions. ClinVar contains an entry for this variant (Variation ID: 547512). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |